Todd Berner is a Boston-based medical professional specializing in incorporating the voice of the patient into healthcare, particularly pertaining to rare diseases and gene therapy. As health economics changes to account for wider representation for rare diseases and technological advancements, Todd advocates for incorporating patient feedback into research and treatment efforts.

Often, individuals affected by rare diseases can feel isolated, particularly if there are a mere dozens of cases in the US. Todd Berner feels that, by connecting these individuals and providing better treatment options through genetic testing and similar, that it can help humanize those that may otherwise be going through a difficult time in their lives.

Todd has been a part of multiple organizations that focus on healthcare economics, including the Patient Engagement in Research Special Interest Group for International Society For Pharmacoeconomics and Outcomes Research (ISPOR), Patient-Centered Outcome Research Institute (PCORI), and the Pharmacy Quality Alliance (PQA).